Cleared Traditional

K212239 - XENOVIEW 3.0T Chest Coil (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
522d
Days
Class 2
Risk

K212239 is an FDA 510(k) clearance for the XENOVIEW 3.0T Chest Coil. Classified as Coil, Magnetic Resonance, Specialty (product code MOS), Class II - Special Controls.

Submitted by Polarean, Inc. (Research Triangle Park, US). The FDA issued a Cleared decision on December 23, 2022 after a review of 522 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Polarean, Inc. devices

Submission Details

510(k) Number K212239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2021
Decision Date December 23, 2022
Days to Decision 522 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
415d slower than avg
Panel avg: 107d · This submission: 522d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MOS Coil, Magnetic Resonance, Specialty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

MethodSense, Inc.
Rita King

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MOS Coil, Magnetic Resonance, Specialty

All 487
Devices cleared under the same product code (MOS) and FDA review panel - the closest regulatory comparables to K212239.
0.55T 12Ch Breast Coil
K260947 · Neocoil, LLC · Apr 2026
HD 8Ch Wrist Array
K252587 · Shenzhen RF Tech Co., Ltd. · Apr 2026
GEM Flex Coil 16-L Array, 3.0T Receive Only
K252876 · Shenzhen RF Tech Co., Ltd. · Apr 2026
Smart Fit TorsoCardiac 1.5T
K260519 · Philips Healthcare (Suzhou) Co., Ltd. · Mar 2026
GEM Flex Coil 16-L Array, 1.5T Receive Only
K252179 · Shenzhen RF Tech Co., Ltd. · Feb 2026
3.0T AIR 32CH HNA
K253738 · Ge Healthcare Coils (Usa Instruments, Inc.) · Jan 2026